US Stock MarketDetailed Quotes

AMPE Ampio Pharmaceuticals

Watchlist
  • 0.003
  • 0.0000.00%
15min DelayClose Dec 20 16:00 ET
2.95KMarket Cap0.00P/E (TTM)

Ampio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-53.30%9.52M
-17.99%2.22M
-75.53%1.4M
-68.72%1.56M
-37.64%4.34M
-0.92%20.38M
-70.73%2.7M
48.58%5.72M
35.80%4.99M
82.35%6.96M
Selling and administrative expenses
-38.26%7.08M
-50.41%973K
-64.00%1.07M
-62.53%1.22M
16.54%3.82M
32.23%11.47M
-56.31%1.96M
136.67%2.98M
131.79%3.25M
115.88%3.28M
-General and administrative expense
-38.26%7.08M
-50.41%973K
-64.00%1.07M
-62.53%1.22M
16.54%3.82M
32.23%11.47M
-56.31%1.96M
136.67%2.98M
131.79%3.25M
115.88%3.28M
Research and development costs
-72.64%2.44M
68.06%1.24M
-88.02%329K
-80.26%344K
-85.79%524K
-25.08%8.92M
-84.40%739K
5.90%2.75M
-23.32%1.74M
60.58%3.69M
Operating profit
53.30%-9.52M
17.99%-2.22M
75.53%-1.4M
68.72%-1.56M
37.64%-4.34M
0.92%-20.38M
70.73%-2.7M
-48.58%-5.72M
-35.80%-4.99M
-82.35%-6.96M
Net non-operating interest income expense
58.18%348K
-34.62%68K
-1.25%79K
206.25%98K
3,333.33%103K
5,400.00%220K
10,300.00%104K
7,900.00%80K
3,100.00%32K
200.00%3K
Non-operating interest income
58.18%348K
-34.62%68K
-1.25%79K
206.25%98K
3,333.33%103K
5,400.00%220K
10,300.00%104K
7,900.00%80K
3,100.00%32K
200.00%3K
Other net income (expense)
-85.93%538K
-75.33%93K
111.96%92K
-96.85%91K
-80.32%262K
9.54%3.83M
-87.45%377K
-446.40%-769K
2,387.93%2.89M
781.46%1.33M
Gain on sale of security
----
----
----
----
----
64.98%5.76M
-87.45%377K
425.68%1.17M
2,387.93%2.89M
781.46%1.33M
Special income (charges)
97.11%-56K
--0
--0
--0
---62K
---1.94M
--0
---1.94M
--0
--0
-Less:Impairment of capital assets
--0
--0
--0
----
----
--1.94M
--0
--1.94M
----
----
-Gain on sale of business
----
----
----
--0
---6K
----
----
----
--0
--0
-Gain on sale of property,plant,equipment
---56K
--0
--0
--0
---56K
--0
--0
--0
--0
--0
Other non- operating income (expenses)
--594K
--93K
--92K
--91K
--324K
----
----
----
----
----
Income before tax
47.16%-8.63M
7.48%-2.05M
80.83%-1.23M
33.77%-1.37M
29.34%-3.98M
4.32%-16.34M
64.33%-2.22M
-76.71%-6.41M
41.79%-2.07M
-53.53%-5.63M
Income tax
Net income
47.16%-8.63M
7.48%-2.05M
80.83%-1.23M
33.77%-1.37M
29.34%-3.98M
4.32%-16.34M
64.33%-2.22M
-76.71%-6.41M
41.79%-2.07M
-53.53%-5.63M
Net income continuous Operations
47.16%-8.63M
7.48%-2.05M
80.83%-1.23M
33.77%-1.37M
29.34%-3.98M
4.32%-16.34M
64.33%-2.22M
-76.71%-6.41M
41.79%-2.07M
-53.53%-5.63M
Minority interest income
Net income attributable to the parent company
47.16%-8.63M
7.48%-2.05M
80.83%-1.23M
33.77%-1.37M
29.42%-3.98M
4.32%-16.34M
64.33%-2.22M
-76.71%-6.41M
41.79%-2.07M
-53.70%-5.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
47.16%-8.63M
7.48%-2.05M
80.83%-1.23M
33.77%-1.37M
29.42%-3.98M
4.32%-16.34M
64.33%-2.22M
-76.71%-6.41M
41.79%-2.07M
-53.70%-5.64M
Basic earnings per share
50.83%-10.66
15.93%-2.48
82.02%-1.53
35.71%-1.8
29.73%-5.2
15.97%-21.68
68.62%-2.95
-57.59%-8.51
53.33%-2.8
-23.33%-7.4
Diluted earnings per share
63.64%-10.66
27.91%-2.48
84.79%-1.53
72.73%-1.8
43.48%-5.2
2.91%-29.32
73.54%-3.44
-73.45%-10.06
-10.00%-6.6
-53.33%-9.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -53.30%9.52M-17.99%2.22M-75.53%1.4M-68.72%1.56M-37.64%4.34M-0.92%20.38M-70.73%2.7M48.58%5.72M35.80%4.99M82.35%6.96M
Selling and administrative expenses -38.26%7.08M-50.41%973K-64.00%1.07M-62.53%1.22M16.54%3.82M32.23%11.47M-56.31%1.96M136.67%2.98M131.79%3.25M115.88%3.28M
-General and administrative expense -38.26%7.08M-50.41%973K-64.00%1.07M-62.53%1.22M16.54%3.82M32.23%11.47M-56.31%1.96M136.67%2.98M131.79%3.25M115.88%3.28M
Research and development costs -72.64%2.44M68.06%1.24M-88.02%329K-80.26%344K-85.79%524K-25.08%8.92M-84.40%739K5.90%2.75M-23.32%1.74M60.58%3.69M
Operating profit 53.30%-9.52M17.99%-2.22M75.53%-1.4M68.72%-1.56M37.64%-4.34M0.92%-20.38M70.73%-2.7M-48.58%-5.72M-35.80%-4.99M-82.35%-6.96M
Net non-operating interest income expense 58.18%348K-34.62%68K-1.25%79K206.25%98K3,333.33%103K5,400.00%220K10,300.00%104K7,900.00%80K3,100.00%32K200.00%3K
Non-operating interest income 58.18%348K-34.62%68K-1.25%79K206.25%98K3,333.33%103K5,400.00%220K10,300.00%104K7,900.00%80K3,100.00%32K200.00%3K
Other net income (expense) -85.93%538K-75.33%93K111.96%92K-96.85%91K-80.32%262K9.54%3.83M-87.45%377K-446.40%-769K2,387.93%2.89M781.46%1.33M
Gain on sale of security --------------------64.98%5.76M-87.45%377K425.68%1.17M2,387.93%2.89M781.46%1.33M
Special income (charges) 97.11%-56K--0--0--0---62K---1.94M--0---1.94M--0--0
-Less:Impairment of capital assets --0--0--0----------1.94M--0--1.94M--------
-Gain on sale of business --------------0---6K--------------0--0
-Gain on sale of property,plant,equipment ---56K--0--0--0---56K--0--0--0--0--0
Other non- operating income (expenses) --594K--93K--92K--91K--324K--------------------
Income before tax 47.16%-8.63M7.48%-2.05M80.83%-1.23M33.77%-1.37M29.34%-3.98M4.32%-16.34M64.33%-2.22M-76.71%-6.41M41.79%-2.07M-53.53%-5.63M
Income tax
Net income 47.16%-8.63M7.48%-2.05M80.83%-1.23M33.77%-1.37M29.34%-3.98M4.32%-16.34M64.33%-2.22M-76.71%-6.41M41.79%-2.07M-53.53%-5.63M
Net income continuous Operations 47.16%-8.63M7.48%-2.05M80.83%-1.23M33.77%-1.37M29.34%-3.98M4.32%-16.34M64.33%-2.22M-76.71%-6.41M41.79%-2.07M-53.53%-5.63M
Minority interest income
Net income attributable to the parent company 47.16%-8.63M7.48%-2.05M80.83%-1.23M33.77%-1.37M29.42%-3.98M4.32%-16.34M64.33%-2.22M-76.71%-6.41M41.79%-2.07M-53.70%-5.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 47.16%-8.63M7.48%-2.05M80.83%-1.23M33.77%-1.37M29.42%-3.98M4.32%-16.34M64.33%-2.22M-76.71%-6.41M41.79%-2.07M-53.70%-5.64M
Basic earnings per share 50.83%-10.6615.93%-2.4882.02%-1.5335.71%-1.829.73%-5.215.97%-21.6868.62%-2.95-57.59%-8.5153.33%-2.8-23.33%-7.4
Diluted earnings per share 63.64%-10.6627.91%-2.4884.79%-1.5372.73%-1.843.48%-5.22.91%-29.3273.54%-3.44-73.45%-10.06-10.00%-6.6-53.33%-9.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List